| Source: |
| Type: |
| MAP3K14 (Mitogen-Activated Protein Kinase Kinase Kinase 14; NF-kB-Inducing Kinase, NIK) — Serine/threonine kinase that functions as a central upstream regulator of the non-canonical NF-kB signaling pathway. NIK activates IKKα, promoting processing of NF-kB2/p100 to p52 and formation of RELB:p52 transcriptional complexes. Typical modulation in cancer: Frequently ↑ or aberrantly stabilized in selected cancers and generally tumor-promoting. Increased NIK activity can support survival, proliferation, inflammatory signaling, immune-cell interactions, and therapy resistance through persistent non-canonical NF-kB activation. Typical mechanistic relationship: Receptor signaling → NIK/MAP3K14 stabilization ↑ → IKKα activation → NF-kB2/p100 processing to p52 ↑ → RELB:p52 nuclear translocation ↑ → non-canonical NF-kB target-gene transcription ↑. |
| 9079- | MGF, | Mangiferin, a novel nuclear factor kappa B-inducing kinase inhibitor, suppresses metastasis and tumor growth in a mouse metastatic melanoma model |
| - | in-vivo, | Melanoma, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1919 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid